| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 10/14/2004 | US20040204441 Nasal delivery of apomorphine |
| 10/14/2004 | US20040204437 Substituted arylamine derivatives and methods of use |
| 10/14/2004 | US20040204425 Sodium channel blockers |
| 10/14/2004 | US20040204424 Such as 4-(4-hydroxyphenyl)butylamidino-3,5-diamino-6-chloropyrazinecarboxamide hydrochloride; time-release agents; for therapy of chronic bronchitis, emphysema, cystic fibrosis, and eye disorders |
| 10/14/2004 | US20040204417 For therapy of cancer |
| 10/14/2004 | US20040204398 Acylated piperazine derivatives as melanocortin-4 receptor agonists |
| 10/14/2004 | US20040204393 Aromatase inhibition to enhance assisted reproduction |
| 10/14/2004 | US20040204355 alpha 7 receptor is the alpha -bungarotoxin sensitive receptor that influences the release of proinflammatory cytokines from macrophages |
| 10/14/2004 | US20040203118 Polynucleotides and polypeptides of the IFNalpha-14 gene |
| 10/14/2004 | US20040203105 for drug screening emzyme inhibitors using genetically engineered animal models; for anticancer agents |
| 10/14/2004 | US20040202739 Compositions and methods for treating female sexual response |
| 10/14/2004 | US20040202736 Method of ameliorating side-effects of SERMs |
| 10/14/2004 | US20040202713 Means and method for hormonal contraception |
| 10/14/2004 | US20040202679 truncated papillomavirus L1 protein consisting of an amino acid sequence having one or more carboxy terminal amino acid residues deleted from a full length L1 amino acid sequence, and amino acid residues from a second protein replacing deleted amino acid residues in the truncated L1 protein. |
| 10/14/2004 | US20040202674 zona pellucida polypeptide, and/or a variant, from a carnivorous mammal, useful in reducing fertility of cats and/or dogs. |
| 10/14/2004 | US20040202617 Delivery of opioids through an inhalation route |
| 10/14/2004 | DE202004012450U1 Delivery unit for administering a medicament into the vaginal cavity of a patient comprises an elongate body with delivery and grip ends, a medicament container, and a piston system |
| 10/14/2004 | CA2519939A1 Bicyclic piperidine derivatives as melanocortin-4 receptor agonists |
| 10/13/2004 | EP1466904A1 Biaryl compound and use thereof |
| 10/13/2004 | EP1466901A1 Serotonine reuptake inhibitor |
| 10/13/2004 | EP1466889A1 Derivatives of venlafaxine and methods of preparing and using the same |
| 10/13/2004 | EP1466609A1 Method of preparing and using isoflavones |
| 10/13/2004 | EP1466604A1 Isoquinoline derivatives, process for their preparation and use thereof in the treatment of melatoninergic system problems |
| 10/13/2004 | EP1465997A2 Use of biomolecular targets in the treatment and visualization of tumors |
| 10/13/2004 | EP1465924A2 Modulators of notch ic protease activity for use in immunotherapy |
| 10/13/2004 | EP1465906A1 Compositions and methods relating to endometrial specific genes and proteins |
| 10/13/2004 | EP1465900A1 Rho-kinase inhibitors |
| 10/13/2004 | EP1465891A2 Inhibitors of dipeptidyl peptidase iv |
| 10/13/2004 | EP1465889A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 10/13/2004 | EP1465888A2 Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues |
| 10/13/2004 | EP1465886A1 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 10/13/2004 | EP1465880A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine |
| 10/13/2004 | EP1465872A1 4-sulfide/sulfoxide/sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor |
| 10/13/2004 | EP1465867A1 Ligands of melanocortin receptors and compositions and methods related thereto |
| 10/13/2004 | EP1465659A2 Use of a novel cell surface protease from group b streptococcus |
| 10/13/2004 | EP1465650A2 Sk-3 potassium channels and the treatment of sexual dysfunctions and/or vascular disorders |
| 10/13/2004 | EP1465635A2 Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues |
| 10/13/2004 | EP1465630A1 Cyclic urea derivatives with 5-ht2c receptor activity |
| 10/13/2004 | EP1465619A1 Suppression of cartilage degradation via the estrogen receptor |
| 10/13/2004 | EP1465602A1 Matrix film tablets for the controlled release of natural mixtures of conjugated estrogen |
| 10/13/2004 | EP1381615B1 ANTIDEPRESSANT INDOLETETRAHYDROPYRIDINE DERIVATIVES OF 2,3-DIHYDRO-7H- [1,4]DIOXINO[2,3-e]INDOLE |
| 10/13/2004 | EP1381613B1 Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-(1,4)-benzodioxans |
| 10/13/2004 | EP1280797B1 Inhibitors of dipeptidyl peptidase iv |
| 10/13/2004 | EP1200151B1 Drug delivery device for insertion into the vagina, rectum or nasal cavity |
| 10/13/2004 | EP1107746B1 Methods of using and compositions comprising dopamine reuptake inhibitors |
| 10/13/2004 | EP1102763B1 Fsh mimetics for the treatment of infertility |
| 10/13/2004 | EP1087786B1 Methods and materials for the treatment of prostatic carcinoma |
| 10/13/2004 | EP1086086B1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 10/13/2004 | EP1079790B1 Use of microbicidal and spermicidal compositions for inactivating non-enveloped viruses |
| 10/13/2004 | EP1007052B1 Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception |
| 10/13/2004 | EP0986389B1 Novel process |
| 10/13/2004 | EP0840616B1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological diseases |
| 10/13/2004 | CN1537112A Pyrimidine compound |
| 10/13/2004 | CN1537111A Urea substituted imidazoquinolines |
| 10/13/2004 | CN1537100A Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
| 10/13/2004 | CN1537009A Method for treating or preventing functional vitamin B12 dificiency in individual and to medical compositions for use in said method |
| 10/13/2004 | CN1537004A Compositions containing imidazotriazinone for nasal application |
| 10/13/2004 | CN1536986A Intravaginal drug delivery devices for administration of antimicrobial agent |
| 10/13/2004 | CN1535957A New isoquinoline compounds, their preparation method and medicine composition contaning them |
| 10/13/2004 | CN1535698A Chinese medicine compound preparation and its preparation process |
| 10/13/2004 | CN1170941C Human BMP-7 promoter and method for exploring bone-related substance by using the same |
| 10/13/2004 | CN1170819C Piperidine alcohols |
| 10/13/2004 | CN1170583C Weilingxian wine |
| 10/13/2004 | CN1170579C Method for preparing capsule for curing gynaecologic inflammation |
| 10/13/2004 | CN1170549C Process for preparing 'Qianjin' capsule to treat genopathy |
| 10/13/2004 | CN1170536C Use of preparing medicine for preventing vomit using tetrahydrobenzo [cd] indole-6-formylamine compound |
| 10/12/2004 | US6803372 Such as cis-n-(4-benzoylphenyl)-4-hydroxy-3'-oxospiro (cyclohexane-1,1' (3'h)-isobenzofuran)-4-carboxamide for use as neuropeptide y receptor antagonist for treatment bulimia, obesity or diabetes |
| 10/12/2004 | US6803365 Imidazo[1,3,5]triazinones and the use thereof |
| 10/12/2004 | US6803211 Cancer therapy |
| 10/12/2004 | US6803189 Methods for the detection of cervical cancer |
| 10/12/2004 | US6803031 Aerosol comprises particles comprising at least 10 percent by weight of an erectile dysfunction drug, such as sildenafil, tadalafil or vardenafil. |
| 10/07/2004 | WO2004084945A1 Eating controllers |
| 10/07/2004 | WO2004084908A1 Prostaglandin compositions for the treatment of erectile dysfunction |
| 10/07/2004 | WO2004084878A1 Compositions and methods for treatment of premature ejaculation |
| 10/07/2004 | WO2004075823A3 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 10/07/2004 | WO2003076427A8 Quinazoline compounds useful in therapy |
| 10/07/2004 | WO2003057725A3 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 10/07/2004 | WO2003049679A3 Mitotic kinesin inhibitors |
| 10/07/2004 | US20040198980 Selective rxr ligands |
| 10/07/2004 | US20040198979 antagonists of urotensin II; (R) N-[4-Chloro-3-(1-methyl-3-pyrrolidinyloxy)-phenyl]-[3-(2-chlorophenoxy)]benzenesulfonamide for example; treating various disease including cardiovascular disorders, gastrointestinal disorders, and psychological disorders |
| 10/07/2004 | US20040198824 enzyme inhibitor; anticancer agents; analgesics; vision defects |
| 10/07/2004 | US20040198799 Methods of increasing endogenous testosterone levels |
| 10/07/2004 | US20040198796 Compounds and methods for treating urinary incontinence |
| 10/07/2004 | US20040198791 Fused imidazole derivative |
| 10/07/2004 | US20040198781 Carbonic anhydrase inhibitor |
| 10/07/2004 | US20040198749 Methods of using sodium channel blockers |
| 10/07/2004 | US20040198748 Antihistamines; bronchodilators; antiinflammatory agents; inflammatory bowel disorders |
| 10/07/2004 | US20040198747 Sodium channel blockers |
| 10/07/2004 | US20040198746 Sodium channel blockers |
| 10/07/2004 | US20040198745 Sodium channel blockers |
| 10/07/2004 | US20040198744 Methods of using phenolic guanidine sodium channel blockers |
| 10/07/2004 | US20040198735 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 10/07/2004 | US20040198717 4-(trifluoromethyl)-7,8,9,10-tetrahydrochromeno[7,6-b]azepin-2(6H)-one and derivatives;4-(trifluoromethyl)-1,6,7,8,9,10-hexahydro-2H-azepino[3,2-g]quinolin-2-one and derivatives; useful in the treating conditions caused by androgen deficiency such as bone disorders |
| 10/07/2004 | US20040198710 suppressing follicle maturation and ovulation and replacing the endogenous ovarian secretion of 17 beta-estradiol; 1,3,5 (10)-estratrien-3, 15 alpha ,16 alpha ,17 beta -tetrol for example; does not employ co-administration of a luteinizing hormone releasing hormone; less side effects |
| 10/07/2004 | US20040198707 kit containing a plurality of daily hormone units for use in a contraceptive method contains three consecutive phases: an estrogenic, a progestogenic and a hormone-free phase |
| 10/07/2004 | US20040198705 Modulation of steroid hormone uptake |
| 10/07/2004 | US20040198682 RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (siNA) |
| 10/07/2004 | US20040198675 Administering macrolide antibiotic |
| 10/07/2004 | US20040198674 Compositions for preventing hormone induced adverse effects |
| 10/07/2004 | US20040198655 recombinant human ptx3 gene as a drug target and diagnostic marker for fertility drugs |